EN
Lymphoma is confusing from the start because it is not one disease but dozens: some grow rapidly and require treatment to begin quickly, others behave so quietly for years that there is no need to hurry into therapy. So the first thing a person with this diagnosis needs to understand is not “how serious is this in general” but “which lymphoma is this”. German haemato-oncology is built around that distinction, and every sensible plan starts from it.
How people usually arrive
Often the trigger is an enlarged lymph node that does not go away, or a finding on an examination done for another reason. The person may already have a report, but without answers to the main questions: which type of lymphoma this is, how far it has spread and whether it is one of the forms that need treating right now. Those are the questions to answer precisely before anything is prescribed.
How the diagnosis is confirmed in Germany
The key to a lymphoma diagnosis is examination of the tissue itself. Usually not simply a fragment of a node is needed but a sufficient sample, so removing or taking the whole lymph node is preferred. A German pathologist examines it in detail: determines the specific subtype of lymphoma using methods that highlight the proteins characteristic of the tumour cells, and where needed looks at the genetic features. Literally everything that follows depends on this.
To establish where the deposits are, imaging is used — CT and often positron emission tomography (PET), which shows not the shape but the activity of tissue and picks out affected lymph nodes throughout the body. The bone marrow is frequently examined too. The result of this stage is not merely “lymphoma” but the exact subtype and the extent, early or more widespread. Only on that basis is it worth talking about treatment.
Which approaches are used
Here a decision can come that patients do not expect: in some slow lymphomas that cause no symptoms it is wiser not to treat but to watch — this is called active surveillance. Treatment begins when it is genuinely needed, not “just in case”. To someone used to the idea that a diagnosis demands immediate action that sounds strange, but behind it is a considered judgement: not to do harm with therapy where the disease is not yet doing any.
When treatment is needed, the basis is most often drug therapy. Classical chemotherapy today almost always goes together with targeted drugs — antibodies that find the mark characteristic of the tumour cells and act on it. For some lymphomas, radiotherapy to the particular area where the disease is concentrated is added. In more difficult situations, high-dose therapy is used with a subsequent transplant of the patient’s own or a donor’s stem cells to restore blood formation. Newer methods working through the immune system also exist and are discussed where there are grounds for them.
As elsewhere in German oncology, the regimen is decided not by one doctor but by a board, and treatment follows approved protocols. A protocol sets a tested frame within which the doctors choose a solution for the particular subtype and the particular person.
When a second opinion makes sense
Precisely because the subtype decides everything, a second opinion is especially valuable here. A review of the tissue and the images by a German specialist sometimes refines the subtype — and the approach changes with it. If the diagnosis has been made but doubts remain, starting with a second opinion is logical: the doctor will say whether they agree with the diagnosis and the plan and whether anything should change before treatment begins.
This material is for information only and does not replace a consultation with a doctor. Whether treatment is possible, what it will involve and what it will achieve can be determined only after an examination at the clinic in person.